Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Salpingectomy to prevent ovarian cancer: A Countercurrents Series.

Literature DB >> 23737681

Salpingectomy to prevent ovarian cancer: A Countercurrents Series.

S A Narod.

Abstract

Entities: Disease

Year: 2013 PMID： 23737681 PMCID： PMC3671018 DOI： 10.3747/co.20.1471

Source DB: PubMed Journal: Curr Oncol ISSN： 1198-0052 Impact factor: 3.677

× No keyword cloud information.

8 in total

1. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.

Authors: A Antoniou; P D P Pharoah; S Narod; H A Risch; J E Eyfjord; J L Hopper; N Loman; H Olsson; O Johannsson; A Borg; B Pasini; P Radice; S Manoukian; D M Eccles; N Tang; E Olah; H Anton-Culver; E Warner; J Lubinski; J Gronwald; B Gorski; H Tulinius; S Thorlacius; H Eerola; H Nevanlinna; K Syrjäkoski; O-P Kallioniemi; D Thompson; C Evans; J Peto; F Lalloo; D G Evans; D F Easton
Journal: Am J Hum Genet Date: 2003-04-03 Impact factor: 11.025

2. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.

Authors: Amy Finch; Mario Beiner; Jan Lubinski; Henry T Lynch; Pal Moller; Barry Rosen; Joan Murphy; Parviz Ghadirian; Eitan Friedman; William D Foulkes; Charmaine Kim-Sing; Teresa Wagner; Nadine Tung; Fergus Couch; Dominique Stoppa-Lyonnet; Peter Ainsworth; Mary Daly; Babara Pasini; Ruth Gershoni-Baruch; Charis Eng; Olufunmilayo I Olopade; Jane McLennan; Beth Karlan; Jeffrey Weitzel; Ping Sun; Steven A Narod
Journal: JAMA Date: 2006-07-12 Impact factor: 56.272

3. Cancer incidence in a population of Jewish women at risk of ovarian cancer.

Authors: Alexander Liede; Beth Y Karlan; Rae Lynn Baldwin; Lawrence D Platt; Graciela Kuperstein; Steven A Narod
Journal: J Clin Oncol Date: 2002-03-15 Impact factor: 44.544

4. Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.

Authors: Andrea Eisen; Jan Lubinski; Jan Klijn; Pal Moller; Henry T Lynch; Kenneth Offit; Barbara Weber; Tim Rebbeck; Susan L Neuhausen; Parviz Ghadirian; William D Foulkes; Ruth Gershoni-Baruch; Eitan Friedman; Gadi Rennert; Teresa Wagner; Claudine Isaacs; Charmaine Kim-Sing; Peter Ainsworth; Ping Sun; Steven A Narod
Journal: J Clin Oncol Date: 2005-10-20 Impact factor: 44.544

Review 5. Epidemiology and primary prevention of cancers of the breast, endometrium, and ovary. A brief overview.

Authors: J L Kelsey; A S Whittemore
Journal: Ann Epidemiol Date: 1994-03 Impact factor: 3.797

6. Oophorectomy after menopause and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

Authors: Joanne Kotsopoulos; Jan Lubinski; Henry T Lynch; Charmaine Kim-Sing; Susan Neuhausen; Rochelle Demsky; William D Foulkes; Parviz Ghadirian; Nadine Tung; Peter Ainsworth; Leigha Senter; Beth Karlan; Andrea Eisen; Charis Eng; Jeffrey Weitzel; Dawna M Gilchrist; Joanne L Blum; Dana Zakalik; Christian Singer; Taya Fallen; Ophira Ginsburg; Tomasz Huzarski; Ping Sun; Steven A Narod
Journal: Cancer Epidemiol Biomarkers Prev Date: 2012-05-07 Impact factor: 4.254

7. Ovarian cancer and hormone replacement therapy in the Million Women Study.

Authors: Valerie Beral; Diana Bull; Jane Green; Gillian Reeves
Journal: Lancet Date: 2007-05-19 Impact factor: 79.321

8. Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers.

Authors: Andrea Eisen; Jan Lubinski; Jacek Gronwald; Pal Moller; Henry T Lynch; Jan Klijn; Charmaine Kim-Sing; Susan L Neuhausen; Lucy Gilbert; Parviz Ghadirian; Siranoush Manoukian; Gad Rennert; Eitan Friedman; Claudine Isaacs; Eliot Rosen; Barry Rosen; Mary Daly; Ping Sun; Steven A Narod
Journal: J Natl Cancer Inst Date: 2008-09-23 Impact factor: 13.506

8 in total

9 in total

Salpingectomy to prevent ovarian cancer: A Countercurrents Series.

1. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.

2. Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.

3. Cancer incidence in a population of Jewish women at risk of ovarian cancer.

4. Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.

Review 5. Epidemiology and primary prevention of cancers of the breast, endometrium, and ovary. A brief overview.

6. Oophorectomy after menopause and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

7. Ovarian cancer and hormone replacement therapy in the Million Women Study.

8. Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers.

Review 1. It's Totally Tubular....Riding The New Wave of Ovarian Cancer Research.

2. Preventing ovarian cancer by salpingectomy.

3. Hysterectomy with opportunistic salpingectomy versus hysterectomy alone.

4. Ovarian cancer risk reduction through opportunistic salpingectomy.

Review 5. Major clinical research advances in gynecologic cancer in 2014.

6. Opportunistic salpingectomy: Remove the tubes and save the ovaries.

Review 7. Cell Origins of High-Grade Serous Ovarian Cancer.

8. Occult tubal carcinoma found at risk reducing salpingectomy in a BRCA1 carrier.

Review 9. Ovarian Cancer: The Fallopian Tube as the Site of Origin and Opportunities for Prevention.